What type of drug is trilaciclib? Understanding this novel myeloprotection therapy
•
3 min read
Approved by the FDA in February 2021, trilaciclib is a novel drug for cancer care. So, **what type of drug is trilaciclib?** It is the first-in-class myeloprotection agent, designed to decrease the incidence of chemotherapy-induced bone marrow suppression.
